Early Consumer Results for T-Mobile Jump! Program NEW YORK,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Early Consumer Results for T-Mobile Jump! Program

NEW YORK, Aug. 7, 2014 (GLOBE NEWSWIRE) -- ITG Market Research today released the results of its latest Early Upgrade Report showing Jump! customers are utilizing the program's early upgrade option to upgrade to the newest flagship devices at significantly higher rates than the customer base as a whole. Since April, the Samsung Galaxy S5 has captured 25% to 30% of all T-Mobile sales each month but captured 40% to 45% of customers upgrading early via Jump! while the HTC One M8 captured 3% to 4% of total handset sales but 5% to 6% of customers upgrading early via Jump!.

Smartphone owners who signed up for T-Mobile's Jump! program last year became eligible to upgrade to a new device this year. The launch of highly publicized flagship devices has had a direct impact on upgrade decisions made by Jump! customers. As the tables below illustrate, Samsung's recapture rate (i.e. existing Samsung customers purchasing another Samsung handset) soared with the launch of Galaxy S5 in April. Additionally, we observed that prior iPhone users jumped to Samsung at significantly higher rates after the launch. Apple owners who bought the iPhone 5 in 2013 and decided to take advantage of their Jump! upgrade in April were evenly split between the iPhone 5S and the new Galaxy S5.

     
Original Apple Smartphone Owners   Original Samsung Smartphone Owners
Upgrade Month to Apple to LG to Samsung   Upgrade Month to Apple to LG to Samsung
Mar-14 50% 12% 25%   Mar-14 21% 15% 51%
Apr-14 44% 4% 43%   Apr-14 9% 5% 80%
May-14 49% 5% 37%   May-14 9% 7% 76%
Jun-14 39% 10% 39%   Jun-14 11% 10% 70%
Source: ITG Market Research
                 

While the share of Jump! upgraders who chose iPhones has not rebounded meaningfully since the S5 launch, more original Apple and Samsung owners have been using Jump! to move to LG's G2 and new L90 recently. "LG appears to be gaining traction and with the launch of the G3 in July, LG has the chance to gain more attention and share in advance of the iPhone 6 this fall," according to Gary Cohen, Director of ITG Market Research.

The ITG Market Research Monthly Early Upgrade Report tracks the advent of the US Carriers' handset purchase installment plans (Verizon Edge, AT&T Next, T-Mobile Jump! and Sprint Framily/Easy Pay). Key metrics tracked are: Attach Rate (% of subscribers who sign up), Time to Convert (days on plan before exercising the upgrade option) and Flow Share (tracking the device traded in and the new device chosen).

To learn more about the Early Upgrade Report and other ITG Market Research offerings, please contact Director Gary Cohen at 415-370-9400 or via email at gary.cohen@itg.com .

About ITG Market Research

ITG Market Research is the primary market research offering of ITG (NYSE: ITG ), an independent global agency brokerage firm. ITG's differentiated research platform is based upon leveraging large amounts of statistically relevant, real-time data. ITG Market Research partners with global mobile data sources to provide unique data-driven reporting and insights throughout the mobile eco-system. From product launches to monthly device sell through tracking, ITG helps clients understand market trends, improve marketing performance, and navigate the increasingly complex mobile device market. For more information, please visit www.itg.com .

© 2014 Investment Technology Group, Inc. All rights reserved. Not to be reproduced or retransmitted without permission. #080614-28322

Investment research products and services are offered by: in the U.S.,  ITG Investment Research, Inc., an affiliate of ITG Inc. (a FINRA Member firm and SIPC Member); in Canada, ITG Canada Corp., member Canadian Investor Protection Fund ("CIPF") and Investment Industry Regulatory Organization of Canada ("IIROC"); in Europe, Investment Technology Group Limited, registered in Ireland No. 283940 ("ITGL") and/or Investment Technology Group Europe Limited, registered in Ireland No. 283939 ("ITGEL") (the registered office of ITGL and ITGEL is First Floor, Block A, Georges Quay, Dublin 2, Ireland and ITGL is a member of the London Stock Exchange, Euronext and Deutsche Börse). ITGL and ITGEL are authorised and regulated by the Central Bank of Ireland; in Asia, ITG Hong Kong Limited (SFC License No. AHD810), ITG Singapore Pte Limited (CMS Licence No. 100138-1), and ITG Australia Limited (AFS License No. 219582). All of the above entities are subsidiaries of Investment Technology Group, Inc.  MATCH Now SM is a product offering of TriAct Canada Marketplace LP ("TriAct"), member CIPF and IIROC. TriAct is a wholly owned subsidiary of ITG Canada Corp.

These materials are for informational purposes only, and are not intended to be used for trading or investment purposes or as an offer to sell or the solicitation of an offer to buy any security or financial product. The information contained herein has been taken from trade and statistical services and other sources we deem reliable but we do not represent that such information is accurate or complete and it should not be relied upon as such. No guarantee or warranty is made as to the reasonableness of the assumptions or the accuracy of the models or market data used by ITG or the actual results that may be achieved. These materials do not provide any form of advice (investment, tax or legal). ITG Inc. is not a registered investment adviser and does not provide investment advice or recommendations to buy or sell securities, to hire any investment adviser or to pursue any investment or trading strategy. All trademarks, service marks, and trade names not owned by ITG are the property of their respective owners. All functionality described herein is subject to change without notice.

ITG Media/Investor Contact: J.T. Farley (212) 444-6259

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading

Top 5 Most Recently Viewed Articles

Future Insights: The Expansion of the Continuous Thermal Monitoring Market

Updated Category News Views 134

The Growth of the Continuous Thermal Monitoring Market The Continuous Thermal Monitoring Market is poised for significant growth, with estimates projecting an increase from around USD 1.00 billion in 2024 to approximately USD 1.49 billion by 2030, marking a compound annual growth rate (CAGR) of 6.8%. This growth trajectory can be attributed to various factors, primarily...

Continue Reading
Revolution Medicines Shares Insights on Zoldonrasib Breakthrough

Updated Category News Views 202

Revolution Medicines Announces New Research Publication Revolution Medicines, Inc. (Nasdaq: RVMD), a pioneering clinical oncology company, has recently made headlines with the publication of an important peer-reviewed research paper. This research, showcased in the prestigious journal Science, focuses on zoldonrasib (RMC-9805), a breakthrough targeted therapy designed to...

Continue Reading
Discover the Future of Crypto Gaming at Jackbit Casino

Updated Category News Views 218

Jackbit Casino: A Leader in Online Gambling As the digital landscape of gambling continues to evolve, Jackbit Casino emerges as a notable player, offering more than 8000 diverse games and an array of exclusive bonuses. This fast-growing brand has been recognized for its innovative approach to crypto gambling, making it an attractive option for players worldwide. Launched...

Continue Reading
Molecular Partners Raises $20 Million to Fuel Innovation in Biotech

Updated Category News Views 308

Molecular Partners Secures $20 Million in Underwritten Offering Molecular Partners AG, a cutting-edge biotech firm, has recently announced that it has priced an underwritten offering of American Depositary Shares (ADSs) in the United States. This offering consists of approximately 3,642,988 ADSs, each representing one ordinary share, priced at $5.49 per share. This...

Continue Reading
NanoXplore's Latest Financial Performance Revealed

Updated Category News Views 181

Insights into NanoXplore's Q4 and Full-Year 2025 Results NanoXplore Inc., a leading graphene company, recently announced its financial results for the fiscal year ending June 30, 2025. While the results showed a decrease in revenues, there are several positive aspects worth noting. Financial Highlights for Q4-2025 The company reported total revenues of $31,685,923 for the...

Continue Reading